top of page


About ADVATx

Premium Fractional Yellow Laser

Combining the gold standard wavelength for eliminating vascular abnormalities with the new gold standard for non-ablative resurfacing, the ADVATx allows the provider to treat 25 FDA/CE-cleared indications without using consumables: one device, multiple stand-alone and combination therapies.


  • Laser Diode: Solid state (crystal)

  • Wavelength: 589nm & 1319nm

  • Spot size: 1,2,3 mm

  • Scanner: 5×5 mm, 7×7 mm, 10×10 mm

  • Fluence: 5 J/cm2 – 60 J/cm2

  • Size: 127 x 58.5 x 58.5 cm (Height × Width × Depth)

  • Weight: 187 lbs (85kg)

  • Consumables: None

  • Supply voltage: 100-240V

  • Certification: FDA 510 (k), CE

Screenshot 2023-01-31 at 10.50.59 PM.png


Single Spot or Fractionated Delivery – Both 589nm and 1319nm are delivered via the same scanner hand piece.

Screenshot 2023-01-31 at 10.56.27 PM.png


In order to minimize the discomfort and unwanted side effects such as purpura, or other damage to surrounding tissue caused by Pulsed Dye Lasers (PDL), ADVATx employs Quasi CW pulsing, delivering individual pulses of energy at a repetition rate of 12 kHz.

As the durations of the individual pulses, as well as the pulse-to-pulse spacings are significantly shorter than the thermal relaxation time of the vessels, the skin perceives the multiple pulses of energy as a single pulse. For example, this means that a 20 ms pulse of energy can be directed at the target, i.e. Veins, without the trauma to the surrounding tissue caused by the significantly larger energy spikes of a PDL.

Simply stated, because of our advanced delivery system, ADVATx allows for all the well-known therapeutic benefits of yellow light, without the undesirable side effects associated with PDL.

It is important to state that the 1319 nm is delivered as a continuous wave, allowing for controlled, gradual bulk heating of tissue for optimal fibroblastic proliferation and reduction of sebum production from sebaceous glands. 

Screenshot 2023-01-31 at 11.00.16 PM.png


ADVATx is based on our patented pulse synchronization, or PulSync, technology.

Consisting of two laser modules, one emitting 1064nm, the other 1319nm, a shared Q-Switch modulates both to generate a pulsed train of light. These pulsed trains are synchronized and simultaneously sent through an LBO, or non-linear crystal, which combines the wavelength of the respective 1064 and 1319 photons to generate 589nm, or yellow, light. Alternatively, 1319nm may be selected, depending on the treatment goals.


bottom of page